ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment (ALTER)

This study has been completed.
Sponsor:
Collaborators:
The Government Pharmaceutical Organization
Chiang Mai University
Information provided by (Responsible Party):
Gonzague Jourdain, Institut de Recherche pour le Developpement
ClinicalTrials.gov Identifier:
NCT01671982
First received: August 17, 2012
Last updated: May 28, 2015
Last verified: May 2015